The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis

M.J. van den Brink*, P. Beelen, M.C. Herman, P.M. Geomini, J.H. Dekker, K.M. Vermeulen, M.Y. Bongers, M.Y. Berger

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2003-2011
Number of pages9
JournalBjog-an International Journal of Obstetrics and Gynaecology
Volume128
Issue number12
Early online date27 Jul 2021
DOIs
Publication statusPublished - Nov 2021

Keywords

  • Cost-effective analysis
  • economic evaluation
  • excessive uterine bleeding
  • intrauterine device
  • menorrhagia
  • menstruation
  • mirena
  • noninferiority trial
  • novasure
  • QUALITY-OF-LIFE
  • CLINICAL EFFECTIVENESS
  • MENORRHAGIA
  • HEALTH
  • HYSTERECTOMY
  • OUTCOMES
  • WOMEN
  • UTILITY
  • SF-36
  • BURDEN

Cite this